Kwang
Chua S. Kwang, Singapore SG
Patent application number | Description | Published |
---|---|---|
20140045280 | METHOD FOR PACKAGING CIRCUITS - A method for packaging integrated circuit chips (die) is described that includes providing a base substrate with package level contacts, coating a base substrate with adhesive, placing dies on the adhesive, electrically connecting the die to the package level contacts, and removing the backside of the base substrate to expose the backside of the package level contacts. Accordingly, an essentially true chip scale package is formed. Multi-chip modules are formed by filling gaps between the chips with an encapsulant. In an embodiment, chips are interconnected by electrical connections between package level contacts in the base substrate. In an embodiment, substrates each having chips are adhered back-to-back with through vias formed in aligned saw streets to interconnect the back-to-back chip assembly. | 02-13-2014 |
Chun Swee Kwang, Singapore SG
Patent application number | Description | Published |
---|---|---|
20100140794 | APPARATUS AND METHOD FOR PACKAGING CIRCUITS - An apparatus comprises an integrated circuit die including a main body having a top layer, a bottom layer, and a peripheral edge surface extending between the top layer and the bottom layer. The integrated circuit die also includes a bond pad on the main body, an edge contact at the peripheral edge surface and a line connecting the bond pad to the edge contact. The edge contact includes a bottom surface that substantially in the same plane as a surface of an encapsulant encasing the die. Additional apparatus, systems, and methods are disclosed. | 06-10-2010 |
Edward M. Kwang, Walnut, CA US
Patent application number | Description | Published |
---|---|---|
20090132579 | SESSION AUDIT MANAGER AND METHOD - A system and method is for managing user session usage on one or more network devices. A session audit agent executes on each of the one or more network devices for collecting application usage data. A session audit services application executes on the one or more network devices for receiving the application usage data from each session audit agent. A session audit web service system executes on a web server that is capable of receiving the application usage data from the session audit service. A session audit manager (SAM) for receives the application usage data from the session audit web service. One or more session usage audit tools is provided as part of the session audit manager for monitoring and analyzing user session usage of the one or more network devices. | 05-21-2009 |
Hakmo Kwang, Goyang-Si KR
Patent application number | Description | Published |
---|---|---|
20120268868 | DISPLAY APPARATUS AND METHOD FOR MANUFACTURING THE SAME - Disclosed are a display device and a manufacturing method thereof, which do not use some of cases and set covers necessary for producing the display device and thus can minimize a thickness and enhance a sense of beauty with an innovative design. The display device includes a display panel, a guide frame, an adhesive member, a set cover, and a soft member. The set cover receives the guide frame, and surrounds a side of the display panel. The soft member is formed at the set cover, and closely contacted to the side of the display panel. | 10-25-2012 |
Ho-Bin Kwang, Hwaseong-Si KR
Patent application number | Description | Published |
---|---|---|
20100308756 | IMAGE FORMING APPARATUS AND METHOD OF CONTROLLING MOTORS THEREOF - An image forming apparatus includes a plurality of motors, a controller which generates control signals to control the plurality of motors and output the control signals, and a plurality of motor drivers which control corresponding motors among the plurality of motors if the enable signal among the control signal is input, and does not control the motors although the common signal is input if the enable signal is not input. Accordingly, the image forming apparatus may control a plurality of motors which is not necessary to be driven at the same time using an enable signal and thus the motors may be effectively controlled with low expense. | 12-09-2010 |
Hwei-Sing Kwang, Singapore SG
Patent application number | Description | Published |
---|---|---|
20090221018 | Procine circovirus type 2 vaccines - The present invention is based on the ORF3 gene of Porcine Circovirus Type 2 (PCV2) and the identification of tis apoptotic role. This discovery has led to the development of an attenuated live vaccine against PCV2. | 09-03-2009 |
20100266585 | Monoclonal Antibodies Specific to Hemagglutinin and Neuraminidase from Influenza Virus H5-Subtype or N1-Subtype and Uses Thereof - Monoclonal antibodies and related binding proteins that bind specifically to the envelope glycoprotein of H5 subtypes or neuraminidase glycoprotein of N1 subtypes of avian influenza virus (AIV) are provided. The monoclonal antibodies and related binding proteins are useful for the detection of H5 and N1 subtypes of AIV, including H5N1 subtypes and provide means for the diagnosis, surveillance and treatment of dangerous viral infections. | 10-21-2010 |
20100297126 | Monoclonal Antibodies Specific to Hemagglutinin from Influenza Virus H5-Subtype and Uses Thereof - Monoclonal antibodies and related binding proteins that are specific for conformational epitopes of avian influenza virus K5 subtype hemagglutinin glycoprotein are provided. The antibodies can be used for the detection and treatment of H5 subtype AIV in specimens. | 11-25-2010 |
20110008871 | Production of Homogeneous Cell Line Highly Permissive To Porcine Circovirus Type 2 (PCV2) Infection - Continuous cell lines that are highly permissive to infection by porcine circovirus type 2 (“PCV2”) are described. PCV2 is the causal agent of post-weaning multi-systemic wasting syndrome (“PMWS”) in pigs. PMWS has emerged as a major disease that poses a significant threat to the economics of global swine industry. The highly permissive cell lines of this invention provide efficient and reliable sources of PCV2 for use in development of vaccines, therapies and diagnostic agents for PMWS. | 01-13-2011 |
20130004496 | MONOCLONAL ANTIBODIES SPECIFIC TO HEMAGGLUTININ AND NEURAMINIDASE FROM INFLUENZA VIRUS H5-SUBTYPE OR N1-SUBTYPE AND USES THEREOF - Monoclonal antibodies and related binding proteins that bind specifically to the envelope glycoprotein of H5 subtypes or neuraminidase glycoprotein of N1 subtypes of avian influenza virus (AIV) are provided. The monoclonal antibodies and related binding proteins are useful for the detection of H5 and N1 subtypes of AIV, including H5N1 subtypes and provide means for the diagnosis, surveillance and treatment of dangerous viral infections. | 01-03-2013 |
20130004497 | MONOCLONAL ANTIBODIES SPECIFIC TO HEMAGGLUTININ AND NEURAMINIDASE FROM INFLUENZA VIRUS H5-SUBTYPE OR N1-SUBTYPE AND USES THEREOF - Monoclonal antibodies and related binding proteins that bind specifically to the envelope glycoprotein of H5 subtypes or neuraminidase glycoprotein of N1 subtypes of avian influenza virus (AIV) are provided. The monoclonal antibodies and related binding proteins are useful for the detection of H5 and N1 subtypes of AIV, including H5N1 subtypes and provide means for the diagnosis, surveillance and treatment of dangerous viral infections. | 01-03-2013 |
20130251715 | MONOCLONAL ANTIBODIES SPECIFIC TO HEMAGGLUTININ FROM INFLUENZA VIRUS H5-SUBTYPE AND USES THEREOF - Monoclonal antibodies and related binding proteins that are specific for conformational epitopes of avian influenza virus H5 subtype hemagglutinin glycoprotein are provided. The antibodies can be used for the detection and treatment of H5 subtype AIV in specimens. | 09-26-2013 |
Hwei-Sing Jimmy Kwang, Singapore SG
Patent application number | Description | Published |
---|---|---|
20110053142 | Binding Protein and Epitope-Blocking Elisa for the Universal Detection of H5-Subtype Influenza Viruses - Monoclonal antibodies and related binding proteins specific to influenza H5 subtype HA protein can be used in serological diagnosis of influenza H5 infection in mammalian and avian serum samples, including human serum samples. Each antibody reacts strongly with a wide variety of strains of H5 subtype and does not show cross-reactivity with non-H5 influenza subtypes. | 03-03-2011 |
20110256141 | Monoclonal Antibodies Specific to the Fusion Peptide From Hemagglutinin From Influenza A Viruses and Uses Thereof - This invention relates to methods and products for the diagnosis, surveillance, prevention, and treatment of influenza A virus infections in animals and humans. More particularly, the invention relates to antibodies and related binding proteins for the detection, prevention and treatment of influenza A viruses. The monoclonal antibodies and related binding proteins of the invention are useful for the treatment of the highly pathogenic H5 subtypes of avian influenza virus (AIV). | 10-20-2011 |
20130202608 | MONOCLONAL ANTIBODY SPECIFIC TO MAJOR NEUTRALIZING EPITOPE OF INFLUENZA H5 HEMAGGLUTININ - The present invention relates to the murine monoclonal antibody 4C2 or to chimeric or humanized monoclonal antibodies specific to a major neutralizing epitope of influenza H5 hemagglutinin and active fragments thereof. The present invention also relates to methods and compositions for the prophylaxis and treatment of H5N1 influenza using such murine or chimeric or humanized monoclonal antibodies or fragments thereof. | 08-08-2013 |
20140127216 | NOVEL EXPRESSION CASSETTE FOR EFFICIENT SURFACE DISPLAY OF ANTIGENIC PROTEINS - An expression cassette, wherein said expression cassette comprises: (a) an ie 1 promoter from white spot syndrome virus or a variant thereof; (b) a nucleic acid sequence encoding an N-terminal gp64 signal peptide or variant thereof, a nucleic acid sequence encoding an antigenic peptide, a nucleic acid encoding a transmembrane region, and a nucleic acid encoding a gp64 cytoplasmic region or variant thereof; in which the promoter is operably linked to the nucleic acid sequence. | 05-08-2014 |
Jimmy Kwang, Singapore SG
Patent application number | Description | Published |
---|---|---|
20120045473 | Biomolecule Surface Display and Uses Thereof - A vaccine for the treatment or prevention of a disease in a subject, wherein said disease is associated with an avian influenza virus, and wherein said vaccine comprises an expression vector comprising a nucleic acid encoding a hemagglutinin peptide, such that in use said hemagglutinin peptide is expressed by said expression vector in said subject. | 02-23-2012 |
Jimmy Hwei-Sing Kwang, Singapore SG
Patent application number | Description | Published |
---|---|---|
20110003278 | H5 Subtype-Specific Binding Proteins Useful for H5 Avian Influenza Diagnosis and Surveillance - The invention provides monoclonal antibodies and related binding proteins that bind specifically to the envelope glycoprotein of H5 subtypes of avian influenza virus (“AIV”). The monoclonal antibodies and related binding proteins are useful for the detection of H5 subtypes of AIV, including the pathogenic H5N1 subtypes. Virus may be detected in formalin preserved, paraffin embeded specimens as well as frozen specimens and biological fluids. Accordingly, the invention provides means for the diagnosis and surveillance of dangerous viral infections. | 01-06-2011 |
20130004943 | H5 Subtype-Specific Binding Proteins Useful for H5 Avian Influenza Diagnosis and Surveillance - The invention provides monoclonal antibodies and related binding proteins that bind specifically to the envelope glycoprotein of H5 subtypes of avian influenza virus (“AIV”). The monoclonal antibodies and related binding proteins are useful for the detection of H5 subtypes of AIV, including the pathogenic H5N1 subtypes. Virus may be detected in formalin preserved, paraffin embedded specimens as well as frozen specimens and biological fluids. Accordingly, the invention provides means for the diagnosis and surveillance of dangerous viral infections. | 01-03-2013 |
20130004944 | H5 Subtype-Specific Binding Proteins Useful for H5 Avian Influenza Diagnosis and Surveillance - The invention provides monoclonal antibodies and related binding proteins that bind specifically to the envelope glycoprotein of H5 subtypes of avian influenza virus (“AIV”). The monoclonal antibodies and related binding proteins are useful for the detection of H5 subtypes of AIV, including the pathogenic H5N1 subtypes. Virus may be detected in formalin preserved, paraffin embeded specimens as well as frozen specimens and biological fluids. Accordingly, the invention provides means for the diagnosis and surveillance of dangerous viral infections. | 01-03-2013 |
20140314777 | MONOCLONAL ANTIBODIES TARGETING NEUTRALIZING EPITOPES ON H5 INFLUENZA VIRUS OF CLADE 2.3 - The present invention relates to murine monoclonal antibodies C, F and H which target major neutralizing epitopes of influenza H5 hemagglutinin of clade 2.3 and active fragments thereof. The present invention also relates to methods and compositions for the prophylaxis and treatment of H5N1 influenza using murine monoclonal antibodies C, F or H or active fragments thereof. The present invention additionally relates to methods and compositions for providing universal protection against H5 influenza viruses using murine monoclonal antibodies C, F or H or fragments thereof together with complementary murine monoclonal antibody or active fragments thereof. The present invention further relates to methods and compositions for the characterization and quantification of H5 expression using these murine monoclonal antibody or fragments thereof. | 10-23-2014 |
Kent Y. Kwang, Saratoga, CA US
Patent application number | Description | Published |
---|---|---|
20090268958 | DUAL-PURPOSE PERTURBATION ENGINE FOR AUTOMATICALLY PROCESSING PATTERN-CLIP-BASED MANUFACTURING HOTSPOTS - One embodiment of the present invention provides a system that automatically processes manufacturing hotspot information. During operation, the system receives a pattern clip associated with a manufacturing hotspot in a layout, wherein the pattern clip comprises a set of polygons in proximity to the manufacturing hotspot's location. Next, the system determines if the pattern clip matches a known manufacturing hotspot configuration. If the pattern clip does not match a known manufacturing hotspot configuration, the system then performs a perturbation process on the pattern clip to determine a set of correction recommendations to eliminate the manufacturing hotspot. By performing the perturbation process, the system additionally determines ranges of perturbation to the set of polygons wherein the perturbed pattern clip does not eliminate the manufacturing hotspot. Subsequently, the system stores the set of correction recommendations and the ranges of perturbation into a manufacturing hotspot database. | 10-29-2009 |
20090271749 | PATTERN-CLIP-BASED HOTSPOT DATABASE SYSTEM FOR LAYOUT VERIFICATION - One embodiment of the present invention provides a system that generates a pattern-clip-based hotspot database for performing automatic pattern-clip-based layout verification. During operation, the system receives a list of pattern clips which specify manufacturing hotspots to be avoided in a layout, wherein each pattern clip comprises a set of geometries in proximity to each other. Next, for each pattern clip, the system perturbs the pattern clip to determine a first range of variations for the constituent set of geometries wherein the perturbed pattern clip no longer causes a manufacturing hotspot. The system then extracts a set of correction guidance descriptions from the first range of variations for correcting the pattern clip. Subsequently, the system stores the pattern clip and the set of correction guidance descriptions in the pattern-clip-based hotspot database. | 10-29-2009 |
Kim Kyung Kwang, Kyoto JP
Patent application number | Description | Published |
---|---|---|
20150366924 | GINSENOSIDE COMPOSITION - The object of the present invention is to provide a ginsenoside composition which can obtain specific and excellent result in terms of efficacy, to various symptoms and diseases. | 12-24-2015 |
Kyu-Ilwan Kwang, Yongin-City KR
Patent application number | Description | Published |
---|---|---|
20110121351 | Organic light emitting diode device and method of manufacturing the same - An organic light emitting diode (OLED) device and a method of manufacturing the same, the OLED device including a substrate, a first electrode on the substrate, a buffer layer on the first electrode, an emission layer on the buffer layer, and a second electrode on the emission layer, wherein the buffer layer includes a transparent conductive oxide, and a metal or metal oxide having a work function lower than a work function of the transparent conductive oxide. | 05-26-2011 |
Matthew Kwang, Old Bridge, NJ US
Patent application number | Description | Published |
---|---|---|
20130041329 | NASAL RINSING DEVICE - The present invention is directed towards a nasal rinsing device also known as a neti pot. The neti pot comprises a container body for holding liquid, a removable cap, and an extended pouring spout that directs a saline solution into nasal passages. The cap provides an adequate liquid-seal and venting for airflow into the interior of the pot. | 02-14-2013 |
Nohyun Kwang, Yongin-Si KR
Patent application number | Description | Published |
---|---|---|
20090087693 | Secondary battery - A secondary battery having a porous filling member that occupies a portion of a molding space between a bare cell and a protective circuit board. The presence of the filling member makes it possible to uniformly apply a molding resin into the molding space and to reduce defects due to thickness irregularity of a mold or a surface defect thereof. The secondary battery includes a bare cell, a protective circuit module including a protective circuit arranged on a protective circuit board and a plurality of electrical connection members electrically connecting the protective circuit board to the bare cell, a filling member arranged between the bare cell and the protective circuit board and a mold covering the electrical connection members and the filling member | 04-02-2009 |
Seok-Hwan Kwang, Suwon-Si KR
Patent application number | Description | Published |
---|---|---|
20100032656 | Phenylcarbazole compounds, organic light emitting device comprising the phenylcarbazole compounds and flat panel display device comprising the organic light emitting device - Provided are a compound represented by Formula 1 or 2 below and an organic light emitting device including an organic layer having the compound: | 02-11-2010 |
Yu Kwang, Seoul KR
Patent application number | Description | Published |
---|---|---|
20090008413 | AIRLESS DISPENSING PUMP CONTAINER WITH AN AIRTIGHT PUSH DOWN TYPE NOZZLE HEAD - An airless dispensing pump container with an airtight push down type nozzle head is disclosed, which comprises a content discharge part which is installed at a nozzle engaging hole of the nozzle head; a ball valve support which is engaged at a lower side of the stem; and a content compression piston support shoulder which is provided at an inner upper wall of the content storing container. In the present invention, a vacuum sealing function is enhanced in the whole structure of the present invention, and a content opening and closing valve member of a content discharge part provided at a nozzle head is automatically opened and closed, along with a reliable discharge of the content, and a reverse flow and leakage are prevented by improving a structure of a content pump piston which sucks and transfers the content. | 01-08-2009 |